Related Experiment Video
Updated: Jun 23, 2026

08:10
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Proliferative vitreoretinopathy: pathobiology and therapeutic targets
Yannek I Leiderman1, Joan W Miller
1Retina Service, The Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA. Yannek Leiderman@meei.harvard.edu
Seminars in Ophthalmology
|April 18, 2009
Abstract:
The cell biology and molecular mediators of proliferative vitreoretinopathy continue to be elucidated. The purpose of this review is to summarize contemporary findings in the visual and neurosciences relevant to the pathophysiology of proliferative vitreoretinopathy, with an emphasis on the biologic mediators that represent potential therapeutic targets.
